CLINICAL_TRIALS
trial_result
· 2019-05-10
Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel [Phase 1, Phase 2]
Summary
Phase 1/2 trial of DRM01B topical gel for acne vulgaris completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dermira, Inc. | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-05-10